PMID: 15238827Jul 9, 2004Paper

Progression of coronary artery disease in non-ischemic dilated cardiomyopathy

Coronary Artery Disease
Olaf HedrichPaul J Hauptman

Abstract

Dilated cardiomyopathy (DCM) is traditionally divided into ischemic and non-ischemic etiologies. We review data from clinical trials that suggest some patients in the latter subgroup develop ischemic complications including fatal myocardial infarction. However, the reasons for and magnitude of the effect are not known. Prospective screening studies and improved endpoint adjudication in clinical trials may be required to better delineate the degree to which the phenomenon occurs. Risk factor modification strategies should be applied to the non-ischemic DCM cohort, especially with continued improvements in survival rates in patients with heart failure.

References

Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Aug 1, 1973·British Heart Journal·R Gorlin, C E Bemis
Dec 8, 1994·The New England Journal of Medicine·G W Dec, V Fuster
Nov 1, 1994·The American Journal of Cardiology·G BortmanM T Olivari
Apr 1, 1993·Circulation·D WatersJ Lespérance
Feb 20, 1997·The New England Journal of Medicine·UNKNOWN Digitalis Investigation Group
Jul 1, 1997·The American Journal of Cardiology·L La VecchiaM Vincenzi
Jul 30, 1999·American Heart Journal·J R Teerlink, B M Massie
Sep 16, 1999·Cleveland Clinic Journal of Medicine·S E Nissen
Apr 13, 2000·The New England Journal of Medicine·G M FelkerE K Kasper
Aug 11, 2000·European Journal of Heart Failure·J G ClelandM Packer
Jun 2, 2001·The New England Journal of Medicine·M PackerUNKNOWN Carvedilol Prospective Randomized Cumulative Survival Study Group

❮ Previous
Next ❯

Citations

Jun 27, 2013·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Lutz FrankensteinHugo A Katus
Mar 24, 2007·Nature Clinical Practice. Cardiovascular Medicine·Michael J LipinskiGeorge W Vetrovec
Aug 20, 2011·International Journal of Clinical Practice·N Verma, V M Figueredo
Feb 28, 2007·Vascular Health and Risk Management·Anna Louise HawkesRichard Speare
May 24, 2011·Vascular Health and Risk Management·Pablo Pazos-LópezAlfonso Castro-Beiras
Dec 8, 2007·Cardiology Clinics·Raghava S Velagaleti, Ramachandran S Vasan
Jan 17, 2009·Journal of the American College of Cardiology·James D FlahertyUNKNOWN Acute Heart Failure Syndromes International Working Group
Jun 24, 2011·PLoS Pathogens·Janina Kristin HellmannFriedrich Frischknecht

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.